Robert Dechant sells and files Form 144 for IBEX (NASDAQ: IBEX)

Rhea-AI Filing Summary

Robert Dechant reported a proposed sale of 6,000 common shares of IBEX under a Rule 144 notice. The filing lists two prior sales in the past three months: 6,000 shares sold on 02/17/2026 for $1,777,786.00 and 6,000 shares sold on 02/18/2026 for $179,853.00.

Insights

Securities Compliance Analyst

Form 144 notice records a proposed sale of 6,000 IBEX common shares by Robert Dechant.

The filing is a Rule 144 disclosure listing the 6,000 shares offered for sale and two prior sales of 6,000 each on 02/17/2026 and 02/18/2026 with the stated amounts. This is a routine insider resale notification under securities resale rules.

Timing and execution mechanics are not specified in the excerpt; subsequent trade reports or a Form 4/144 amendment may clarify actual sale completion.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	RBC CAPITAL MARKETS LLC 250 NICOLLET MALL, SUITE 1700 MINNEAPOLIS MN 55401	6000	178358.00	13405520	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	12/28/2018	RSA VEST	ISSUER			6000	12/28/2018	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROBERT DECHANT C/O RBC CAPITAL MARKETS LLC 250 NICOLLET MALL MINNEAPOLIS MN 55401	IBEX LTD	02/17/2026	6000	1777786.00
ROBERT DECHANT C/O RBC CAPITAL MARKETS LLC 250 NICOLLET MALL MINNEAPOLIS MN 55401	IBEX LTD	02/18/2026	6000	179853.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does IBEX Form 144 from Robert Dechant disclose?

It discloses a proposed sale of 6,000 common shares of IBEX under Rule 144 and lists two recent sales of 6,000 shares on 02/17/2026 and 02/18/2026 with stated dollar amounts.

Does the Form 144 confirm the 6,000 shares were sold?

No. The filing shows a proposed sale of 6,000 shares. It separately reports two prior sales of 6,000 shares on 02/17/2026 and 02/18/2026, which are reported as past transactions.

Who is the reporting person on the IBEX Form 144?

The filing identifies Robert Dechant as the reporting person, with broker details listed as RBC Capital Markets LLC at 250 Nicollet Mall, Minneapolis, MN in the excerpt.

What amounts are shown for prior sales on the Form 144?

The document lists prior sales of 6,000 shares on 02/17/2026 for $1,777,786.00 and 6,000 shares on 02/18/2026 for $179,853.00 as provided in the excerpt.

Will this Form 144 change IBEX share count or outstanding shares?

No. This Form 144 is a resale notice for 6,000 shares and does not alter authorized or outstanding share counts; it records an intended or proposed resale by the reporting person.